Dr. Tan Li Ping will lead clinical care across DaVita’s 40+ dialysis centres nationwide.
KUALA LUMPUR, 01 December 2021 - DaVita Malaysia Sdn Bhd has appointed Dr. Tan Li Ping as Chief Medical Officer (CMO) starting 1st December 2021. With more than 20 years of international clinical and academic experience, Dr. Tan will help guide DaVita in its next phase of development as an industry leader in holistic renal care.
“Throughout his career, Dr. Tan has proven to be a very driven and dynamic individual. His track record in both academia and clinical practice is exactly what we need to further elevate clinical standards, with a relentless focus on patient outcomes and quality of life,” expressed Matt Williams, CEO of DaVita Malaysia.
As CMO, Dr. Tan will have clinical oversight of 2,000+ patients across DaVita’s 40 clinics. Along with helping expand the network, Dr. Tan will work to broaden the company’s efforts to prevent the progression of Chronic Kidney Disease (CKD), develop hospital-based acute services, establish a Peritoneal Dialysis (PD) offering, expand DaVita’s clinical research program, and support patient transplantation.
“Around the world, DaVita already provides these holistic kidney care services to hundreds of thousands of patients. Under Dr. Tan’s leadership, we are excited to build on the existing best-practices in Malaysia and accelerate the adoption of global innovation,” said Matt Williams.
Dr. Tan most recently served Ramsay Sime Darby Health Care as Consultant Nephrologist, Director of Dialysis Service and a member of the Medical Advisory Board. Prior to his roles as consultant nephrologist and physician in various hospitals, Dr. Tan was also the Medical Director, Head of the Internal Medicine Department at the Oriental Melaka Straits Medical Centre. He also has an extensive history in research, peer-reviewed publications and academia that earned him several prestigious accolades in the US, Canada and Malaysia.